TrialCancer immunology, immunotherapy : CII2022

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.

Yulong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.